Posted in | News | Nanobusiness

US-Based Vendum Batteries Becomes Member of NanoKTN

A battery technology development firm located in the U.S.,Vendum Batteries, announces that it has become a member of the Nano Knowledge Transfer Network (NanoKTN). NanoKTN is a Government agency that leads and supports the commercialization of nanotechnologies in the UK.

Vendum Batteries’ CEO, Fraser Cottington, states that the alliance with the nanotechnology commercialization agency allows the start up company to divide the risk associated with investment through partnerships and focus on cutting edge battery technology.

NanoKTN supports formation of networks, partner brokering, research and development, and industry partnerships, as well as to access commercialization grant schemes ranging from $7,500 to $390,000. The developing battery technology company expects that through the membership in NanoKTN, the company can easily secure grants for improving their R&D process and for starting pre -production prototypes. The membership also allows Vendum to work closely with several Universities, businesses, and individuals. This can help the company to establish strong supply chain partnerships that ensures long term future.

Source: http://www.vendumbatteries.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 12). US-Based Vendum Batteries Becomes Member of NanoKTN. AZoNano. Retrieved on November 23, 2024 from https://www.azonano.com/news.aspx?newsID=22016.

  • MLA

    Chai, Cameron. "US-Based Vendum Batteries Becomes Member of NanoKTN". AZoNano. 23 November 2024. <https://www.azonano.com/news.aspx?newsID=22016>.

  • Chicago

    Chai, Cameron. "US-Based Vendum Batteries Becomes Member of NanoKTN". AZoNano. https://www.azonano.com/news.aspx?newsID=22016. (accessed November 23, 2024).

  • Harvard

    Chai, Cameron. 2019. US-Based Vendum Batteries Becomes Member of NanoKTN. AZoNano, viewed 23 November 2024, https://www.azonano.com/news.aspx?newsID=22016.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.